Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis

Viral infections cause many severe human diseases, being responsible for remarkably high mortality rates. In this sense, both the academy and the pharmaceutical industry are continuously searching for new compounds with antiviral activity, and in addition, face the challenge of developing greener an...

Full description

Bibliographic Details
Main Authors: Everton M. da Silva, Hérika D. A. Vidal, Arlene G. Corrêa
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/14/11/1125
_version_ 1827675712699498496
author Everton M. da Silva
Hérika D. A. Vidal
Arlene G. Corrêa
author_facet Everton M. da Silva
Hérika D. A. Vidal
Arlene G. Corrêa
author_sort Everton M. da Silva
collection DOAJ
description Viral infections cause many severe human diseases, being responsible for remarkably high mortality rates. In this sense, both the academy and the pharmaceutical industry are continuously searching for new compounds with antiviral activity, and in addition, face the challenge of developing greener and more efficient methods to synthesize these compounds. This becomes even more important with drugs possessing stereogenic centers as highly enantioselective processes are required. In this minireview, the advances achieved to improve synthetic routes efficiency and sustainability of important commercially antiviral chiral drugs are discussed, highlighting the use of organocatalytic methods.
first_indexed 2024-03-10T05:09:45Z
format Article
id doaj.art-329eb120dc67468ea2c2713f848ed14d
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T05:09:45Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-329eb120dc67468ea2c2713f848ed14d2023-11-23T00:55:37ZengMDPI AGPharmaceuticals1424-82472021-11-011411112510.3390/ph14111125Advances on Greener Asymmetric Synthesis of Antiviral Drugs via OrganocatalysisEverton M. da Silva0Hérika D. A. Vidal1Arlene G. Corrêa2Centre of Excellence for Research on Sustainable Chemistry, Department of Chemistry, Federal University of São Carlos, São Carlos 13565-905, SP, BrazilCentre of Excellence for Research on Sustainable Chemistry, Department of Chemistry, Federal University of São Carlos, São Carlos 13565-905, SP, BrazilCentre of Excellence for Research on Sustainable Chemistry, Department of Chemistry, Federal University of São Carlos, São Carlos 13565-905, SP, BrazilViral infections cause many severe human diseases, being responsible for remarkably high mortality rates. In this sense, both the academy and the pharmaceutical industry are continuously searching for new compounds with antiviral activity, and in addition, face the challenge of developing greener and more efficient methods to synthesize these compounds. This becomes even more important with drugs possessing stereogenic centers as highly enantioselective processes are required. In this minireview, the advances achieved to improve synthetic routes efficiency and sustainability of important commercially antiviral chiral drugs are discussed, highlighting the use of organocatalytic methods.https://www.mdpi.com/1424-8247/14/11/1125antiviralsgreen chemistryselectivityasymmetric synthesisorganocatalysis
spellingShingle Everton M. da Silva
Hérika D. A. Vidal
Arlene G. Corrêa
Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis
Pharmaceuticals
antivirals
green chemistry
selectivity
asymmetric synthesis
organocatalysis
title Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis
title_full Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis
title_fullStr Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis
title_full_unstemmed Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis
title_short Advances on Greener Asymmetric Synthesis of Antiviral Drugs via Organocatalysis
title_sort advances on greener asymmetric synthesis of antiviral drugs via organocatalysis
topic antivirals
green chemistry
selectivity
asymmetric synthesis
organocatalysis
url https://www.mdpi.com/1424-8247/14/11/1125
work_keys_str_mv AT evertonmdasilva advancesongreenerasymmetricsynthesisofantiviraldrugsviaorganocatalysis
AT herikadavidal advancesongreenerasymmetricsynthesisofantiviraldrugsviaorganocatalysis
AT arlenegcorrea advancesongreenerasymmetricsynthesisofantiviraldrugsviaorganocatalysis